SelectQuote 2027 Q1 Earnings Call
Review the key takeaways and the transcript of this earnings call.
- Fiscal 1Q 2027 revenue was $280 million, down 15% from a year ago, while adjusted EBITDA loss improved by $15 million year over year to $17 million.
- Trailing 12-month adjusted EBITDA was $124 million, up 30% from the prior trailing 12-month period.
- Senior revenue was $51 million, down $8 million year over year, and adjusted EBITDA loss improved by $9 million to $12 million; trailing 12-month senior EBITDA increased 18% to $157 million.
- Healthcare services revenue was $186 million compared with $221 million a year ago; adjusted EBITDA increased 56% year over year to $11 million from $7 million.
- Healthcare services EBITDA per SelectRx member was $108, over 60% higher than a year ago, while profitability per SelectRx member increased 60% year over year.
- Life revenue was $43 million, down $4 million year over year; adjusted EBITDA rose 31% to $7 million, a 17% margin and an improvement of more than 500 basis points.
- SelectQuote outperformed internal forecasts and Street estimates for adjusted EBITDA and operating cash flow in fiscal 1Q.
STOCKNOW INSIGHTS
Continue with outlook and guidance.
Log in to unlock executive comments and Q&A highlights.
Log in for the full summaryStockNow uses AI to translate and summarize earnings calls. Accuracy and completeness are not guaranteed.
Transcript
Preview the first fifteen paragraphs, organized by speaker.
Good morning and welcome to SelectQuote's first quarter 2027 earnings conference call. All lines have been placed on mute to prevent any background noise. After the speaker's remarks, there will be a question-and-answer session. If you would like to ask a question during this time, simply press star followed by the number 1 on your telephone keypad. If you would like to withdraw your question, press the star and one again. It is now my pleasure to introduce Matt Gunter, SelectQuote Investor Relations. Mr. Gunter, you may begin the conference.
Thank you and good morning, everyone. Welcome to SelectQuote's fiscal first quarter earnings call. Before we begin our call, I would like to mention that on our website, we have provided a slide presentation to help guide our discussion. After today's call, a replay will also be available on our website. Joining me from the company, I have our Chief Executive Officer, Tim Danker, and Chief Financial Officer, Ryan Clement. Following Tim and Ryan's comments today, we will have a question-and-answer session. As referenced on slide two, during this call, we will be discussing some non-GAAP financial measures. The most directly comparable GAAP financial measures and a reconciliation of the differences between the GAAP and non-GAAP financial measures are available in our earnings release and investor presentation on our website. Finally, a reminder that certain statements made today may be forward-looking statements.
These statements are made based upon management's current expectations and beliefs concerning future events impacting the company, therefore involve a number of uncertainties and risks, including but not limited to those described in our earnings release, Form 10-K for the fiscal year ended June 30, 2026, and subsequent filings with the SEC. Therefore, the actual results of operations or financial condition of the company could differ materially from those expressed or implied in our forward-looking statements. With that, I would like to turn the call over to our Chief Executive Officer, Tim Danker.
Tim? Thank you, Matt, and thank you to everyone joining us this morning.
I will begin with an overview of SelectQuote's performance highlights for our first fiscal quarter of 2027. Then I will discuss planning and expectations for this Medicare Advantage season, which is off to a strong start. Lastly, I will provide details on SelectQuote's Evergreen initiative to leverage technology and AI as part of our North Star goal to maximize profitability and cash flow for shareholders. Let me start on slide three with an overview of our first quarter. SelectQuote outperformed both our internal forecasts and street estimates for both EBITDA and operating cash flow. Specifically, our adjusted EBITDA loss of $17 million represents more than $15 million of year-over-year improvement. As a reminder, our first quarter is a seasonal low for our business as we invest and prepare for this year's AEP and OEP seasons.
On a trailing 12-month basis, our adjusted EBITDA totaled $124 million, representing a 30% increase from the prior trailing 12-month period. We are proud of this operational execution, especially in light of the revenue headwinds our industry faced in the past year. As previously discussed, the Inflation Reduction Act negatively impacted top-line results for our Healthcare Services segment. Additionally, as we noted last quarter, we took a conservative hiring approach for Senior this season, given the dynamic MA environment. As a result, consolidated revenue for fiscal 1Q totaled $280 million, or 15% lower than a year ago. More broadly, we believe our payer partners are making significant progress towards their profitability targets, and as the nation's leading direct-to-consumer distributor, we are well-positioned to return to growth as payer priorities shift back towards growth in the future.
With that perspective, SelectQuote's strong year-over-year performance in profitability and cash flow becomes that much more impressive and continues to validate our operating strategy and execution. Before we turn to the season ahead, let me give some quick segment highlights. In Senior, SelectQuote's differentiated outreach capabilities are already driving strong early season results as policyholders navigate another year of plan changes. For fiscal 1Q, our Senior business recognized an adjusted EBITDA loss of $12 million, which is a $9 million improvement compared to a year ago. Turning to Healthcare Services, we continue to succeed in scaling profitability, with adjusted EBITDA improving 56% year over year to $11 million for fiscal 1Q. Similar to our consolidated results, the profit improvement is particularly notable given the 16% decline in revenue primarily caused by the Inflation Reduction Act.
We believe a significant and increasingly important indicator of success is the profitability per SelectRx member, which increased 60% compared to a year ago. On the heels of the strong execution, we are pleased to reiterate our consolidated target of at least $60 million of operating cash flow in fiscal 2027. While we expect another dynamic year for Medicare Advantage, our model is purpose-built to serve customers during times like these. While early, we have seen increased customer engagement during the first few weeks of AEP and remain focused on retention, given continued elevated levels of plan disruption. We have said before the business is positioned to deliver strong margins in a range of selling environments. Our confidence in the strategy is underpinned by both the power of our agents as well as increasing efficiency captured through technology and AI.
As I mentioned, we are well-positioned to further expand profitability and cash flow in future seasons when the opportunities to accelerate top-line growth become more attractive. If you turn to slide four, I will discuss our expectations and strategy for this Medicare Advantage season. Similar to recent years, this AEP is marked by continued disruption as carriers further refine plan features and benefits. SelectQuote planned accordingly. We expect our agent-led model will again produce results that benefit policyholders, carrier partners, and our investors. In fact, early results in AEP are encouraging, as proactive engagement with customers has been well received. This engagement helps improve our visibility into dynamics like recapture rate and benefit demand patterns for new policyholders. Specifically, we enter this AEP with a high mix of tenured agents who historically perform about two times the average productivity of a new agent.
Additionally, these agents have already had conversations with over 50% of our beneficiaries experiencing plan terminations this season. This proactive focus on policyholder retention has been foundational to SelectQuote's operational success in recent years. As I noted before, we have a lot of confidence in the strategy and have a goal to exceed last year's recapture results. As you know, we took a cautious approach to hiring this season given the continued market disruption and our focus on cash flow. However, we believe we are nearing an inflection point for the Medicare Advantage industry. Carriers have largely right-sized their business, and more importantly, have better aligned benefits to fit their economic objectives. In fact, some carrier partners have publicly commented that they're expecting targeted growth where profitability and long-term viability have been demonstrated.
We're encouraged by these signs and continue to hear indications that industry conditions are improving, with carriers noting that they are tracking ahead of target profitability for Medicare Advantage plans. Strategically, SelectQuote remains focused on profitability and cash flow in fiscal 2027. That said, our agent and technology-enabled model remains nimble and can drive incremental growth when attractive opportunities emerge. Our new agent class, while intentionally smaller for this environment, was trained over the summer and is well ramped heading into the season. Similarly, we've added agent tools designed to support both policyholder retention and new policy growth, especially in areas including HMOs, special needs plans, and underserved geographies. Put plainly, SelectQuote's senior business remains focused on expanding profitability, but we are also primed for growth when our carrier partners accelerate their own policy growth efforts.
Before Ryan reviews our financials, let me provide an update on how SelectQuote is leveraging technology and AI to drive value for shareholders on slide five. As you recall from last quarter, we identified and removed over $30 million in permanent run rate costs from our business as part of our fiscal 2027 operating plan. SelectQuote's commitment to technology as a core pillar of our model drives the majority of these cost savings. Here, we wanted to highlight several tangible, measurable examples across both our senior and Healthcare Services businesses. What differentiates SelectQuote is that we are applying AI and technology across the entire value chain, from customer acquisition and enrollment to coaching, quality assurance, and pharmacy fulfillment. In senior, AI is helping us become more efficient while simultaneously improving the beneficiary experience. Today, more than one-third of incoming calls are screened and routed using AI.
Every agent call is transcribed and analyzed, giving agents real-time support during conversations to help improve the customer experience. Managers are then provided post-call scorecards they can use to further improve coaching and training. These measures save a significant amount of time, human resources, and similarly, can flip a bad experience for a customer into a good one. These capabilities are especially valuable for newer agents, helping them ramp faster and perform more consistently during the most important periods of the selling season. We're also seeing meaningful benefits to agent productivity, driven by our voice AI tools. In Q1, one of our tools screened over 200,000 unique calls, saving over 600,000 minutes of valuable agent talk time.
Given these results, we've expanded the strategy across the enterprise, and most notably into our Medicare distribution process during the Annual Enrollment Period, increasing productivity and allowing our licensed agents to focus more time and attention on the more complex portion of the calls. Under this new workflow, our skilled agents will continue to handle the robust needs analysis portion of the call, helping beneficiaries select the optimal plan for their specific needs. From there, our voice AI enrollment agent takes over to guide the beneficiary through the formal enrollment. These tools do not replace our licensed agents. Instead, AI-supported enrollment handles the administrative lifting so our agents can spend time where it matters most, guiding seniors through increasingly complex Medicare choices. This capability is particularly critical during our peak season, allowing us to efficiently scale when beneficiary demand historically exceeds agent capacity.
The same philosophy is driving results in Healthcare Services, where our automated enrollment capabilities are completing enrollments roughly 20% faster while also producing higher enrollment rates. The result is a better experience for members, more productive agents, and a more scalable operating model. The link between technology, AI, and our purpose-built facility in Olathe, Kansas, has been an essential part of the ramp we're driving in segment profitability. As we've noted, the facility itself is running about 30% higher efficiency compared to legacy distribution sites. The improvement in efficiency for those who have visited the site is relatively obvious in the technology hardware we've invested in. We are increasingly excited about the potential of our new pharmacy management system. We view the PMS as a missing link for Healthcare Services segment and an asset that will drive growth and efficiency in the years ahead. So what is the PMS system?
FULL TRANSCRIPT
Continue the full translated transcript in StockNow.
Log in to unlock every statement, the English original, and speaker-by-speaker history.
Log in for the full transcriptCall participants
10 people spoke on this call — only 2 are shown here.
PARTICIPANT LIST
View participant details in StockNow.
Log in to see executives and analysts, their roles, and complete speaking history.
Log in to view all participantsKeep exploring
